A

Andrew Lee

About

Detail

California, United States

Timeline


work
Job
school
Education
folder
Project
auto_stories
Publication

Résumé


Jobs verified_user 0% verified
  • Mercor
    Project Contractor
    Mercor
    Jan 2024 - Current (2 years 6 months)
    Partnered on exploratory Al projects across surgical, oncology, urology, internal medicine, and other clinical domains, applying hands-on clinical expertise to advance innovative solutions in diagnostics, treatment guidance, and decision support. Acted as a clinical liaison between medical teams and Al developers, bridging healthcare knowledge and technical development to maximize model relevance, safety, and impact. Assessed Al-generated outputs for diagnostic accuracy, clinical clarity, and alignment with established medical standards across surgical, oncology, urology, internal medicine, and other specialties. Delivered expert feedback on model performance, edge cases, and complex clinical scenarios to guide iterative improvements and en
  • C
    Diagnostic and Interventional Radiologist
    Central Valley Imaging Medical Associates
    Jan 2020 - Current (6 years 6 months)
    Performs a wide range of image-guided procedures, including tumor ablations, embolizations, drainages, vascular access, and urologic interventions, with extensive experience in joint surgical cases requiring close intraoperative collaboration. Partnered with urology teams on prostate, kidney, and bladder cancer cases, advising on procedural options, performing targeted biopsies, and delivering minimally invasive therapies tailored to urologic oncology. Partnered with surgical and urologic colleagues on hybrid cases, integrating interventional radiology into operative workflows to expand therapeutic options, improve patient safety, and shorten recovery times. Performs and interprets multiple diagnostic imaging modalities, including X-ray, fl
  • University of California, San Francisco
    Clinical Fellow and Instructor, Interventional Radiology
    University of California, San Francisco
    Jan 2019 - Jan 2020 (1 year 1 month)
    Participated in multiple clinical trials, which included therapeutic administration of experimental agents (immunomodulators and CAR-T therapies), treatments of multiple types of cancers, and enrollment/follow up of clinical trial participants, as well as experimental medical devices. Contributed to the treatment of a variety of cancers including but not limited to hepatobiliary cancer, pancreatic cancer, colon cancer, GU cancer, gynecologic malignancies, breast cancer, and melanomas. Participated in and led multidisciplinary discussions including HPB surgery tumor board, GU tumor board, solid organ transplant, and HCC tumor board. Performed a variety of interventional oncology procedures including, but not limited to intra-arterial bland e
  • University of California, Davis
    Residency, Diagnostic Radiology
    University of California, Davis
    Jan 2015 - Jan 2019 (4 years 1 month)
    Performed and interpreted diagnostic imaging across multiple modalities (CT, MRI, ultrasound, fluoroscopy, and X-ray) in subspecialties including neuro, thoracic, Gl, musculoskeletal, breast, and urologic radiology. Actively participated in multidisciplinary tumor boards for orthopedic, gynecologic, thoracic, urologic, breast, Gl, and neuro-oncology cases, contributing imaging expertise to guide treatment decisions. Collaborated with across numerous specialties to provide image-guided procedures, including biopsies, drainages, and minimally invasive interventions. Supported clinical trials through imaging-based treatment response assessment and direct administration of investigational agents under protocol supervision. Engaged in resident a
  • C
    Internship, Internal Medicine
    California Pacific Medical Center
    Jan 2014 - Jan 2015 (1 year 1 month)
    Completed a 12-month internship with 6 months dedicated to intensive care and 6 months on general medicine wards at a 50-bed academic ICU within a high-acuity tertiary care hospital. Managed critically ill patients requiring advanced cardiopulmonary monitoring, ventilator support, invasive hemodynamic monitoring, and use of life support devices. Trained in acute management of shock, stroke, sepsis, and multi-organ failure, as well as emergency response protocols including Code Blue leadership. Participated in airway management, ventilator adjustments, and invasive bedside procedures under supervision. Admitted and managed patients through the hospital's 24-hour on-call service, providing continuous care from admission through stabilization
  • U
    Research Associate and Lab Manager
    UCSF Eli and Edythe Broad Center of Regeneration Medicine
    Jan 2007 - Jan 2011 (4 years 1 month)
    Studied the role of microRNAs in the regenerative capabilities of the liver and liver cancer, differentiation of induced pluripotent stem cells into functional hepatocytes, gene therapy vectors such as AAV, and alternatives to traditional solid-organ liver transplantation via stem cell technology and cellular transplantation. Managed finances, lab inventory/resources, lab staffing/onboarding, and assisted in grant writing/applications.
  • U
    Research Assistant
    UC Berkeley, Department of Molecular and Cell Biology
    Jan 2005 - Jan 2007 (2 years 1 month)
    Research projects included natural killer cell biology, oncology, innate immunity, and viral immune evasion/defense mechanisms. Studied the role of natural killer cells in tumor suppression (NK immuno-oncology).
  • S
    Research Assistant
    Stanford University, Department of Surgery
    Jan 2003 - Jan 2004 (1 year 1 month)
    Studied the role of activating receptors in the setting of natural killer cell-mediated transplant rejection.
Education verified_user 0% verified
  • University of California, Los Angeles
    Master's Program in Business Administration, M.B.A.
    University of California, Los Angeles
    Jan 2021 - Jan 2024 (3 years 1 month)
    Honors, Entrepreneurship and Ventures Focus
  • University of California, San Francisco
    Medical School, M.D.
    University of California, San Francisco
    Jan 2010 - Jan 2014 (4 years 1 month)
  • University of California, Berkeley
    College, B.A. Molecular & Cell Biology
    University of California, Berkeley
    Jan 2003 - Jan 2007 (4 years 1 month)
Projects (professional or personal) verified_user 0% verified
  • M
    Mental Health App Development
    Jan 2015 - Jan 2018 (3 years 1 month)
    Founder and leader for a group developing iOS and Android apps that that help teenagers and young adults track mental health symptoms for depression and anxiety. Software was eventually incorporated into the UC Berkeley Student Health mental health screening programs
  • M
    Medical Blog Writing and Management
    Jan 2014 - Current (12 years 6 months)
    Founder and manager of a health and science blog with the goal of developing interest and literacy in science and medicine, and being able to explain complex medical and scientific ideas in lay language to the general public. Currently with a staff of approximately 40 writers, editors, and administrative staff (www.morningsignout.com)
  • P
    Pre-Medical Mentoring & Advising Program
    Jan 2013 - Current (13 years 6 months)
    Founder of an advising program for undergraduates interested in medicine and other healthcare careers, currently with 18000+ members. Prepared and presented talks to pre-medical students at colleges, and coached numerous students throughout the medical school application process
Publications verified_user 0% verified
  • L
    Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticos
    Mar 2024
  • R
    Real-world evidence in the United States (US) of the impact of bridging therapy prior to axicabtagene ciloleucel (Axi-Ce
    Nov 2023
  • A
    Axicabtagene ciloleucel (Axi-Cel) in patients with relapsed/refractory indolent non-Hodgkin lymphoma: 4-year follow-up f
    Nov 2023
  • F
    Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymp
    May 2023
  • N
    Non-operative management of biliary complications after Liver Transplantation in pediatric patients: A 30-year experienc
    May 2021
  • A
    Acceptability of an mHealth breast cancer risk-reduction intervention promoting risk assessment, education, and discussi
    Jan 2021
  • O
    Outcomes of Balloon occlusion in the University of California Morbidly Adherent Placenta Registry.
    Feb 2020
  • V
    Vascular Plug-Assisted Retrograde Transvenous Obliteration for the Treatment of Acute Hemorrhage from Rectosigmoid Varic
    Sep 2018
  • N
    Non-standardized terminology to describe focal liver lesions in patients at risk for HCC: implications regarding clinica
    Jan 2018
  • T
    Toxicity of Liver-Directed Therapies for Hepatocellular Carcinoma.
    Jan 2017
  • A
    A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away fr
    Jan 2015
  • B
    Benefits of an Informal Curriculum: Recruiting Medical Students Into Interventional Radiology.
    Sep 2014
  • O
    Outcomes of Metallic Biliary Stent Insertion in Patients with Malignant Bilobar Obstruction.
    Jul 2013
  • P
    Percutaneous transhepatic balloon dilation of biliary-enteric anastomotic strictures after surgical repair of iatrogenic
    Oct 2012
  • A
    Acquired A amyloidosis from injection drug use presenting with atraumatic splenic rupture in a hospitalized patient: a c
    Jan 2011
  • I
    Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver re
    Sep 2010
  • T
    Therapeutic liver reconstitution with murine cells isolated long after death.
    Sep 2010
  • M
    MicroRNAs control hepatocyte proliferation during liver regeneration.
    May 2010
  • L
    Loss of p21 permits carcinogenesis from chronically damaged liver and kidney epithelial cells despite unchecked apoptosi
    Jul 2008